WuShuo has learned that 'BNB MicroStrategy' company Windtree Therapeutics received a notice from Nasdaq on August 19, 2025, stating that its common stock will be delisted from the Nasdaq Capital Market and transferred to OTC trading on August 21 due to failure to meet the minimum closing price maintenance standard (Rule 5550(a)(2)). Previously, the company announced plans to raise up to $520 million through equity financing, with 99% of the funds intended for purchasing BNB. https://www.(wublock123.com)/index.php?m=content&c=index&a=show&catid=6&id=47458